Crossmark

Advancing evidence-based regulation: Organization for the Study of Sex Differences and Society for Women’s Health Research support FDA action on menopausal hormone therapy and encourage broader sex-informed drug label updates

Crossref DOI link: https://doi.org/10.1186/s13293-026-00838-4

Published Online: 2026-01-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cunningham, Rebecca L. https://orcid.org/0000-0001-5984-5516
Galea, Liisa A.M. https://orcid.org/0000-0003-2874-9972
Goulmamine, Syreen https://orcid.org/0009-0008-8331-326X
Kararigas, Georgios https://orcid.org/0000-0002-8187-0176
Schubert, Kathryn G. https://orcid.org/0000-0003-1043-9597
Zuloaga, Kristen L. https://orcid.org/0000-0002-5395-7362
Ahmed, Sofia B. https://orcid.org/0000-0003-3000-2229
License Information

Text and Data Mining valid from 2026-01-25

Version of Record valid from 2026-02-17
More Information

Article History

Received: 21 December 2025

Accepted: 19 January 2026

First Online: 25 January 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.